Terms: = Breast cancer AND CTCF, P49711, 10664, ENSG00000102974 AND Treatment
18 results:
1. Telocinobufagin, a PLK1 suppressor that inhibits tumor growth and metastasis by modulating CDC25c and ctcf in HNSCC cells.
Li J; Ma R; Lv JL; Ren YS; Tan YJ; Wang HM; Wang ZE; Wang BS; Yu JN; Wang YL; Tian J; Zheng QS
Phytomedicine; 2024 May; 127():155440. PubMed ID: 38452691
[TBL] [Abstract] [Full Text] [Related]
2. BAP18 facilitates ctcf-mediated chromatin accessible to regulate enhancer activity in breast cancer.
Sun G; Wei Y; Zhou B; Wang M; Luan R; Bai Y; Li H; Wang S; Zheng D; Wang C; Wang S; Zeng K; Liu S; Lin L; He M; Zhang Q; Zhao Y
Cell Death Differ; 2023 May; 30(5):1260-1278. PubMed ID: 36828916
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.
Zhang L; Sun S; Zhao X; Liu J; Xu Y; Xu L; Song C; Li N; Yu J; Zhao S; Yu P; Fang F; Xie J; Ji X; Yu R; Ou Q; Zhao Z; Li M
Mol Oncol; 2022 Oct; 16(20):3689-3702. PubMed ID: 35971249
[TBL] [Abstract] [Full Text] [Related]
4. ctcf and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1.
Wong KM; Song J; Wong YH
Sci Rep; 2021 Jan; 11(1):491. PubMed ID: 33436746
[TBL] [Abstract] [Full Text] [Related]
5. Estrogen Receptor Alpha Mutations in breast cancer Cells Cause Gene Expression Changes through Constant Activity and Secondary Effects.
Arnesen S; Blanchard Z; Williams MM; Berrett KC; Li Z; Oesterreich S; Richer JK; Gertz J
Cancer Res; 2021 Feb; 81(3):539-551. PubMed ID: 33184109
[TBL] [Abstract] [Full Text] [Related]
6. A CRISPR-Cas9 screen identifies essential ctcf anchor sites for estrogen receptor-driven breast cancer cell proliferation.
Korkmaz G; Manber Z; Lopes R; Prekovic S; Schuurman K; Kim Y; Teunissen H; Flach K; Wit E; Galli GG; Zwart W; Elkon R; Agami R
Nucleic Acids Res; 2019 Oct; 47(18):9557-9572. PubMed ID: 31372638
[TBL] [Abstract] [Full Text] [Related]
7. Targeting ctcfL/BORIS for the immunotherapy of cancer.
Loukinov D
Cancer Immunol Immunother; 2018 Dec; 67(12):1955-1965. PubMed ID: 30390146
[TBL] [Abstract] [Full Text] [Related]
8. The Genomic Landscape of Endocrine-Resistant Advanced breast cancers.
Razavi P; Chang MT; Xu G; Bandlamudi C; Ross DS; Vasan N; Cai Y; Bielski CM; Donoghue MTA; Jonsson P; Penson A; Shen R; Pareja F; Kundra R; Middha S; Cheng ML; Zehir A; Kandoth C; Patel R; Huberman K; Smyth LM; Jhaveri K; Modi S; Traina TA; Dang C; Zhang W; Weigelt B; Li BT; Ladanyi M; Hyman DM; Schultz N; Robson ME; Hudis C; Brogi E; Viale A; Norton L; Dickler MN; Berger MF; Iacobuzio-Donahue CA; Chandarlapaty S; Scaltriti M; Reis-Filho JS; Solit DB; Taylor BS; Baselga J
Cancer Cell; 2018 Sep; 34(3):427-438.e6. PubMed ID: 30205045
[TBL] [Abstract] [Full Text] [Related]
9. Luminal lncRNAs Regulation by ERĪ±-Controlled Enhancers in a Ligand-Independent Manner in breast cancer Cells.
Miano V; Ferrero G; Rosti V; Manitta E; Elhasnaoui J; Basile G; De Bortoli M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462945
[TBL] [Abstract] [Full Text] [Related]
10. Apicidin and docetaxel combination treatment drives ctcfL expression and HMGB1 release acting as potential antitumor immune response inducers in metastatic breast cancer cells.
Buoncervello M; Borghi P; Romagnoli G; Spadaro F; Belardelli F; Toschi E; Gabriele L
Neoplasia; 2012 Sep; 14(9):855-67. PubMed ID: 23019417
[TBL] [Abstract] [Full Text] [Related]
11. A co-ordinated interaction between ctcf and ER in breast cancer cells.
Ross-Innes CS; Brown GD; Carroll JS
BMC Genomics; 2011 Dec; 12():593. PubMed ID: 22142239
[TBL] [Abstract] [Full Text] [Related]
12. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
Meeran SM; Patel SN; Tollefsbol TO
PLoS One; 2010 Jul; 5(7):e11457. PubMed ID: 20625516
[TBL] [Abstract] [Full Text] [Related]
13. BORIS (ctcfL) is not expressed in most human breast cell lines and high grade breast carcinomas.
Hines WC; Bazarov AV; Mukhopadhyay R; Yaswen P
PLoS One; 2010 Mar; 5(3):e9738. PubMed ID: 20305816
[TBL] [Abstract] [Full Text] [Related]
14. A ctcf-independent role for cohesin in tissue-specific transcription.
Schmidt D; Schwalie PC; Ross-Innes CS; Hurtado A; Brown GD; Carroll JS; Flicek P; Odom DT
Genome Res; 2010 May; 20(5):578-88. PubMed ID: 20219941
[TBL] [Abstract] [Full Text] [Related]
15. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors.
Xu J; Huo D; Chen Y; Nwachukwu C; Collins C; Rowell J; Slamon DJ; Olopade OI
Breast Cancer Res Treat; 2010 Apr; 120(3):593-601. PubMed ID: 19466541
[TBL] [Abstract] [Full Text] [Related]
16. Selective apoptosis of breast cancer cells by siRNA targeting of BORIS.
Dougherty CJ; Ichim TE; Liu L; Reznik G; Min WP; Ghochikyan A; Agadjanyan MG; Reznik BN
Biochem Biophys Res Commun; 2008 May; 370(1):109-12. PubMed ID: 18355444
[TBL] [Abstract] [Full Text] [Related]
17. Differential regulation of the serotonin transporter gene by lithium is mediated by transcription factors, CCCTC binding protein and Y-box binding protein 1, through the polymorphic intron 2 variable number tandem repeat.
Roberts J; Scott AC; Howard MR; Breen G; Bubb VJ; Klenova E; Quinn JP
J Neurosci; 2007 Mar; 27(11):2793-801. PubMed ID: 17360901
[TBL] [Abstract] [Full Text] [Related]
18. Heightened expression of ctcf in breast cancer cells is associated with resistance to apoptosis.
Docquier F; Farrar D; D'Arcy V; Chernukhin I; Robinson AF; Loukinov D; Vatolin S; Pack S; Mackay A; Harris RA; Dorricott H; O'Hare MJ; Lobanenkov V; Klenova E
Cancer Res; 2005 Jun; 65(12):5112-22. PubMed ID: 15958555
[TBL] [Abstract] [Full Text] [Related]
